Daniel Nemunaitis
Greater Chicago Area,United States
Find Daniel Nemunaitis's Email
Find Daniel Nemunaitis’s PhoneDaniel Nemunaitis's Overview
Dr. Daniel K. Nemunaitis is a highly respected oncologist and researcher, currently serving as the Executive Medical Director at Mary Crowley Cancer Research in Dallas, Texas. He is recognized for his extensive work in the development of novel cancer therapies, particularly in the fields of gene therapy, immunotherapy, and virotherapy. With decades of experience, Dr. Nemunaitis has been a principal investigator on numerous Phase I and Phase II clinical trials, focusing on bringing innovative treatments to patients with various types of cancer. His research aims to translate scientific discoveries into effective clinical applications, offering new hope to individuals battling complex malignancies. He is also an author and co-author of numerous peer-reviewed publications and book chapters, contributing significantly to the body of knowledge in oncology.
Professional Summary
Daniel Nemunaitis's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
Notable Achievements
Executive Medical Director at Mary Crowley Cancer Research
Leads a prominent cancer research organization focused on early-phase clinical trials, pioneering new cancer treatments.
Pioneer in Gene Therapy and Virotherapy for Cancer
Has made significant contributions to the development and clinical testing of gene-based therapies and oncolytic viruses to combat cancer.
Extensive Clinical Trial Leadership
Served as a principal investigator for a multitude of Phase I and II clinical trials, crucial for evaluating the safety and efficacy of new anti-cancer agents.
Author of Numerous Scientific Publications
Has published extensively in peer-reviewed medical journals, sharing critical findings and advancing the field of oncology.
Innovator in Immunotherapy
Contributed to the understanding and application of immunotherapies, harnessing the body's immune system to fight cancer.
Educational Background
Bachelor's degree, Business Administration and Management, General
Kent State University
Buying Intent Signals for Daniel Nemunaitis
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Company Overview
United Franchise GroupUnited Franchise Group (UFG) is a global leader for entrepreneurs, housing a diverse portfolio of affiliated brands and consultants. With decades of experience in the franchising industry, UFG provides comprehensive training, support, and resources to help individuals achieve their goals of business ownership across various sectors including signs, food, retail, and business services. Their model focuses on empowering franchisees with proven systems and ongoing guidance.
Highperformr's free tools for company research
Find contact info
Get verified emails, phone numbers, and LinkedIn profile details
Find similar contacts
Discover contacts with similar roles, seniority, or companies
Perform deep contact research
Uncover insights like skills, work history, social links, and more
Discover, research and enrich contacts with Highperformr — Smarter, Faster
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
- Track signals like job change, promotion, and LinkedIn activity
- Enrich contacts with verified email, phone, and social data instantly
- Automate enrichment and updates with powerful workflows
- Sync enriched contact info directly into your CRM and tools
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.